PET-Based Radiogenomics Supports mTOR Pathway Targeting for Hepatocellular Carcinoma

Scientists explored the genomic and molecular underpinnings of HCC with increased fluorine-18 fluorodeoxyglucose uptake in positron emission tomography (PET) and identified therapeutic targets based on this imaging-genomic surrogate.